• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kilitch Drugs (India) Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3630.0
  • ISIN : INE729D01010
360.05 -3 (-0.70%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    352.00

  • Today’s High

    379.00

  • Open

    357.20

  • Perv Close

    362.60

  • 52W Low

    300.00

  • 52W High

    404.95

Key Indicators

  • P/E(TTM)

    24.62

  • Mar.Cap (₹Cr.)

    579.04

  • Div & Yield %

    0.00

  • Book Value(₹)

    147.27

  • Debt-Equity Ratio

    -0.70

  • AGM Date

    01-Apr-2025

  • EPS

    14.57

  • P/E Ratio

    24.62

Financials Ratios

  • Debt-Equity Ratio

    0.16

  • Mar.Cap (₹Cr.)

    579.04

  • RONW (%)

    8.28

  • ROCE (%)

    13.30

Score Board

  • Equity (₹ in Cr.)

    16.08

  • BV (₹)

    147.30

  • Sales( ₹ in Cr.)

    131.60

  • NP (in Cr.)

    16.71

  • NP Var(%)

    12.0

  • Div%

    0.0

  • CPS (₹)

    11.20

  • EPS (₹)

    10.40

  • Traded Value (₹ in Lakhs)

    576.95

  • 52 Week High

    404.95

  • 52 Week Low

    300.00

  • Price BSE

    359.0

  • Price NSE

    360.00

  • Market Capital( in Cr.)

    576.95

  • P/C Ratio

    32.20

  • P/E Ratio

    34.60

  • Price Vs.BV

    10.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 131.60 117.78 105.16 70.02 60.77 96.42
Excise Duty 130.83 117.02 103.88 69.62 57.02 95.57
Net Sales 131.60 117.78 105.16 70.02 60.77 96.42
Other Income 6.19 4.60 4.56 4.19 5.71 4.52
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 137.79 122.38 109.72 74.21 66.48 100.94
EXPENDITURE :
Raw Materials 130.83 117.02 103.88 69.62 57.02 95.57
Power & Fuel Cost 130.83 117.02 103.88 69.62 57.02 95.57
Employee Cost 7.91 7.47 6.15 5.22 5.65 5.23
Other Manufacturing Expenses 3.40 4.04 3.38 2.37 0.61 4.26
Selling & Administrative Expenses 26.71 23.08 16.48 11.11 11.12 12.13
Miscellaneous Expenses 3.40 4.04 3.38 2.37 0.61 4.26
Less : Pre-operative Expenses Capitalised :
Total Expenditure 114.43 102.93 95.79 66.70 61.25 81.41
Operating Profit 7.05 7.52 7.91 7.05 6.24 5.22
Interest 1.91 0.99 0.66 0.75 0.72 0.38
Gross Profit 23.35 19.45 13.93 7.51 5.22 19.52
Depreciation 1.24 1.34 0.96 1.14 1.15 1.20
Profit Before Tax 23.35 19.45 13.93 7.51 5.22 19.52
Tax 6.37 4.20 3.63 1.67 0.70 4.29
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.59 -0.47 -0.23 -0.31 0.07 0.52
Reported Net Profit 17.57 15.72 10.53 6.16 4.46 14.77
Extraordinary Items 23.35 19.45 13.93 7.51 5.22 19.52
Adjusted Net Profit 17.57 15.72 10.53 6.16 4.46 14.77
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.77
P & L Balance carried down 17.57 15.72 10.53 6.16 4.46 14.77
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 5.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.50
Earnings Per Share-Unit Curr 11.03 10.09 6.76 3.98 2.89 10.06
Book Value 0.00 0.00 0.00 0.00 0.00 0.77
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.77

Shareholding Pattern

  • Promoter Group

    69.23%

  • Public Share Holding

    30.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 6,629,342 41.22 6,629,342 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,504,831 28.01 4,504,831 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,134,173 69.23 11,134,173 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 19 0.00 19 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 119 0.00 119 2
2] Non Institution
Bodies Corporate 221,917 1.38 220,817 61
Clearing Members 470 0.00 470 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 200 0.00 0 1
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 164,102 1.02 164,102 134
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 169,192 1.05 169,192 251
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,497,945 9.31 1,497,945 17
Individuals holding nominal share capital up to Rs. 1 lakh 2,642,306 16.43 2,283,034 9,661
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 232,916 1.45 232,916 1
Sub Total 4,948,027 30.77 4,587,455 10,133
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,082,319 100.00 15,721,747 10,139

Company Background

Kilitch Drugs (India) LtdPharmaceuticals - Indian - Formulations

  • Kilitch Drugs (India) Ltd
  • BSE Code : 3630.0
  • ISIN : INE729D01010

  • Incorporation Year

    1992

  • Registered Office

    C-301/2 MIDC TTC Indl Area
    Pawane Village, Thane,
    Maharashtra-400705

  • Telephone

    91-022-27670322/27680913/65144185

  • FAX

    91-022-27680912

  • Chairman

    Mukund P Mehta

  • Managing Director

    Mukund P Mehta

  • Company Secretary

    Pushpa Nyoupane

  • Auditor

    Suryaprakash Maurya & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Kilitch Drugs (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kilitch Drugs 358.75 137.79 131.60 24.62 10.74
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92